TRPM2 and glioblastoma: Selenium-mediated TRPM2 activation also enhanced ROS production and cell death in glioblastoma cells after treatment with docetaxel (Ertilav et al., 2019), an important antineoplastic agent used in the management of multiple metastatic and non-resectable tumor types (Farha and Kasi, 2023).